Pfizer Inc. Announces Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2017; Provides Earnings Guidance for the Year 2018
For the full year, the company reported revenues were $52,546 million compared to $52,824 million a year ago. Net Income was $21,308 million or $3.52 per diluted share compared to $7,215 million or $1.17 per diluted share a year ago. Adjusted Income was $16,085 million or $2.65 per diluted share compared to $14,761 million or $2.40 per diluted share a year ago.
For the year 2018, the company now expects to report revenues in the range of $53.5 to $55.5 billion and adjusted Diluted earnings per share in the range of $2.90 to $3.00. Effective tax rate on adjusted income is expected to be approximately 17%. Adjusted SI&A Expenses in the range of $14.0 to $15.0 billion. Adjusted R&D Expenses in the range of $7.4 to $7.9 billion.